Search This Blog

Friday, July 31, 2020

Takeda Pharmaceutical misses on revenue

Takeda Pharmaceutical (NYSE:TAK): Q1 Non-GAAP EPS of ¥122.00; GAAP EPS of ¥53.00.
Revenue of ¥801.9B misses by ¥3.34B.
Press Release

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)